Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited announced the sale of a significant portion of shares by its former CEO, John Cullity. The transaction involved the disposal of 236,248 ordinary shares, resulting in a substantial decrease in Cullity’s holdings. This move could potentially impact investor perception and market dynamics, as it reflects a major change in the shareholding pattern of a key figure in the company.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a range of products and services across these industries. The company is a prominent player in the Australasian market, focusing on distribution and logistics of healthcare, medical, and pharmaceutical products.
Average Trading Volume: 138,242
Technical Sentiment Signal: Sell
Current Market Cap: A$5.17B
Learn more about EBO stock on TipRanks’ Stock Analysis page.